Invitrogen™ Human CDIP1 Synthetic Peptide

Ref.: BL-RE-175966Manufacturer ref.: PEP-0812 50 μg
€149.00 excl. VAT

CDIP Synthetic Peptide, PEP-0812, from Invitrogen.

Gene ID (Enter)
29965
Species
Human
Purification method
Purified
Accession number
Q9H305
Common name
Human CDIP1
Brand
Invitrogen

CDIP Synthetic Peptide, PEP-0812, from Invitrogen.

CDIP Synthetic Peptide, PEP-0812, from Invitrogen.

The p53 tumor-suppressor gene integrates numerous signals that control cell life and death; loss of its functions contributes to the development of most cancers. CDIP is a novel pro-apoptotic target gene whose inhibition abrogates p53-mediated apoptotic responses. Overexpression of CDIP induced apoptosis in transfected cells while siRNA suppression of caspase-8 mRNA blocked this CDIP-induced apoptosis, indicating that the CDIP-dependent apoptosis pathway proceeds through extrinsic cell death pathway. CDIP may thus represent a novel target for drug design to maximize p53 response and sensitize tumor cells to cancer therapy. Multiple isoforms of CDIP are known to exist.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15369040
Specifications
Gene ID (Enter)29965
SpeciesHuman
Purification methodPurified
Accession numberQ9H305
Common nameHuman CDIP1
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)CDIP1
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-0812
Country of originUnited States
HS customs code3824 99 92 00
A question or a specific configuration?
Contact us for a quote.